Iview Therapeutics Inc.

This study tested a new gel (IVIEW 1201) against standard antibiotic eye drops (ofloxacin) for treating acute bacterial conjunctivitis (pink eye). About 129 people took part. The goal was to see if the gel works better at clearing up redness and discharge after 8 to 14 days of tr…

This study tested an eye gel called IVIEW-1201 in 135 people with viral pink eye (adenoviral conjunctivitis). The gel contains povidone-iodine, a disinfectant, and is designed to clear the infection and reduce symptoms like redness and discharge. The trial compared the gel to a p…

This study tested three different ways to use an eyelid wipe (IVW-1001) for people with dry eye disease. Thirty adults took part to see how safe and effective each method was. The main goal was to measure changes in tear production and vision.

This study tested a medicated eyelid wipe called IVW-1001 in 150 adults with dry eye disease. The goal was to see if it safely improves tear production and eases symptoms like discomfort. Participants used the wipe on their eyelids, and doctors measured changes in tear amount and…

This study tested a new eyelid wipe called IVW-1001 in 15 people with dry eye disease. Researchers compared three different ways of using the wipe to see which is safest and best at improving tear production. The goal is to find a simple, effective way to ease dry eye symptoms.